CCL2 Antikörper (Magnetic Particles)
Kurzübersicht für CCL2 Antikörper (Magnetic Particles) (ABIN1690230)
Target
Alle CCL2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) antibody
CCL2 Reaktivität: Human, Maus, Affe WB, IHC, ELISA, ICC, FACS Wirt: Maus Monoclonal 2D8 unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) (AA 61-148) antibodyCCL2 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC (p), IF (p), IHC (fro), IF (cc) Wirt: Kaninchen Polyclonal unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) (AA 62-89), (C-Term) antibodyCCL2 Reaktivität: Human WB, IHC (p), IF, FACS Wirt: Kaninchen Polyclonal RB17838 unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) antibodyCCL2 Reaktivität: Human WB, IHC, ELISA, IHC (p), IF, FACS Wirt: Maus Monoclonal 2D8 unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) (AA 24-96) antibodyCCL2 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Maus Monoclonal C1 unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) antibodyCCL2 Reaktivität: Human, Maus, Affe WB, IHC, ELISA, IF/ICC, FACS Wirt: Maus Monoclonal unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) (AA 62-89) antibodyCCL2 Reaktivität: Human WB, IHC, ELISA, IF, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) antibodyCCL2 Reaktivität: Human, Maus, Affe WB, IHC (p), IF, FACS, EIA Wirt: Maus Monoclonal 2D8 unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) (AA 31-80) antibodyCCL2 Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) (AA 24-99) antibodyCCL2 Reaktivität: Human WB, IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Lagerung
- 4 °C
-
-
- CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))
-
Andere Bezeichnung
- MCP-1
-
Pathways
- Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, ER-Nucleus Signaling, Unfolded Protein Response, Phosphorylierungen bei SARS-CoV-2 Infektion
Target
-
